Spravato (esketamine) is one of the most operationally complex psychiatric treatments in routine US practice. It is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation, must be administered under the Spravato REMS program at a certified treatment site, requires direct observation for at least 2 hours after each dose, and cannot be dispensed for home use. Patients arrive with a long list of practical questions and a smaller number of clinical ones. SleekAI is configured to handle the first set and route the second.

The bot reads your WordPress site for the answers a coordinator would give. Induction phase is twice-weekly for the first 4 weeks, maintenance moves to weekly then every 2 weeks. Each session includes intranasal self-administration with the supervising team in the room, vitals taken at baseline and at the 40-minute mark, and the 2-hour observation. Your published wp_posts Spravato pages and the wp_postmeta price and insurance fields are the source of truth; the bot does not invent a coverage answer it cannot verify.

What it never does is discuss dosing, comment on whether a specific antidepressant history qualifies a patient as treatment-resistant, or estimate response likelihood. Those decisions sit with the psychiatrist and the REMS-certified team. The bot refuses with a consistent script, points at the published TRD criteria you list, and books the psychiatric evaluation through SimplePractice or your scheduling tool.

Spravato is the rare psychiatric treatment where the patient experience is governed by a federal risk evaluation and mitigation strategy program, and where every public-facing communication has to respect that program. The 2-hour observation, the in-clinic-only administration, the no-driving rule, and the dispensing prohibition are not marketing details, they are conditions of the certification your clinic holds. A generic chatbot drops those facts in casual conversation, sometimes paraphrasing them into a wrong answer, and the patient arrives unprepared.

SleekAI keeps the REMS language pinned to every relevant response. It also handles the part of Spravato volume that most exhausts a front desk: the prior authorization research, the TRD eligibility framing, the induction-phase scheduling logistics, and the cash-pay quote for patients between insurance plans. Those conversations cluster heavily in evenings and weekends when the billing team is offline and a patient is alone with their search history.

A bot that quotes the same numbers your coordinator quotes, refuses every individual eligibility question with a clean script, and books the psychiatric screening call into the same SimplePractice or Jane App slot your team already uses keeps the experience consistent across the hours your clinic is closed. The psychiatrist still owns the clinical decisions. The bot just runs the front door.